Armin Rashidi

Dr. Armin Rashidi is an Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and Associate Professor in the Clinical Research Division at Fred Hutch Cancer Center. He is a physician-scientist specializing in blood cancers with a focus on microbiome interactions.

Education:

• MD, Tehran University of Medical Sciences (2006)
• PhD in Biogerontology, Newcastle University (2010)
• Internal Medicine Residency, Eastern Virginia Medical School (2013)
• Hematology and Medical Oncology Fellowship, Washington University in St. Louis (2016)

Research Focus: His work investigates how microbiome dysbiosis from cancer treatments affects outcomes in hematologic malignancies. He develops strategies to prevent treatment complications through microbiome modulation, bridging oncology, immunology, and microbial ecology. Current clinical trials explore fecal microbiota transplantation for graft-versus-host disease prevention and microbiome dynamics in leukemia.

Clinical Leadership: Dr. Rashidi leads multiple clinical trials at Fred Hutch including studies on oral/stool microbiota in cancer patients and gut microbiome analysis in chronic lymphocytic leukemia. His translational research directly informs patient care protocols for stem cell transplantation and cellular therapy.